Showing results (721-730 of 955) with videos related to
Sort By:
Pageof 96
Frontiers in Oncology|January 26, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapySilvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, et al.NPJ Breast Cancer|February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclibSylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.Plos One|January 30, 2010
Rapid species diagnosis for invasive candidiasis using mass spectrometryCarine Marinach-Patrice, Arnaud Fekkar, Ralitsa Atanasova, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2014
Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacyEric François, David Azria, Sophie Gourgou-Bourgade, et al.Journal of Inherited Metabolic Disease|October 7, 2025
Allopurinol Treatment Improves Cognitive Skills, Adaptive Behavior, and Biochemical Markers in Young Patients With Adenylosuccinate Lyase DeficiencyBérangère Rousselot-Pailley, Michaela Semeraro, Fabienne Marquant, et al.Future Oncology (London, England)|February 6, 2025
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trialHélène Bellio, Nicolas Roussot, Aurélie Bertaut, et al.Cancer Treatment Reviews|October 29, 2015
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)Paul Sargos, Stéphane Guerif, Igor Latorzeff, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.Emerging Infectious Diseases|December 21, 2021
Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, FranceArnaud Jabet, Sophie Brun, Anne-Cecile Normand, et al.Cancer Research|March 8, 2000
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacyS R Wedge, D J Ogilvie, M Dukes, et al.Pageof 96